Douglas Vincent Faller, Chief Medical Officer of Imunon, Inc. (NASDAQ:IMNN), filed a Form 4 on October 27, 2026, reporting two acquisitions of common stock on October 23, 2026, totaling 27,833 shares received as non-cash compensation.

Key Highlights

  • Stock grant: Faller acquired 26,741 shares of common stock on October 23, 2026, at a price of $1.235 per share, described in the filing as a "Stock Grant."
  • Salary-in-lieu shares: A separate acquisition of 1,092 shares on the same date, also at $1.235, was described as "Stock granted in lieu of cash for portion of base salary."
  • Post-transaction holdings: Following the 26,741-share grant, Faller directly held 74,760 shares; following the 1,092-share grant, a separate directly held position shows 48,019 shares.
  • Transaction code: Both transactions carried code "A" (acquisition), with no shares disposed of in either entry.
  • Signatory: The form was signed by Jeffrey W. Church as Attorney in Fact for Douglas Faller, and filed on October 27, 2026.

Imunon CMO Receives Shares in Lieu of Cash Compensation in October 2026

According to the Form 4 filed with the SEC, Douglas Vincent Faller, serving as Chief Medical Officer of Imunon, Inc., reported two separate acquisitions of common stock, both dated October 23, 2026. The first transaction involved 26,741 shares at a stated price of $1.235 per share, characterized in the filing's remarks section as a "Stock Grant." The second transaction covered 1,092 shares at the same per-share price of $1.235, described as "Stock granted in lieu of cash for portion of base salary."

Both transactions are reported as direct ownership and carry transaction code "A," indicating acquisitions. No disposals of securities were reported. Following the 26,741-share transaction, the filing lists Faller's directly held beneficial ownership at 74,760 shares. The 1,092-share transaction is reported on a separate line, with a resulting directly held position of 48,019 shares, consistent with the filing's use of separate lines for each class or category of securities beneficially owned.

The filing reports no derivative securities activity in Table II. Jeffrey W. Church signed the form as Attorney in Fact for Douglas Faller on October 27, 2026. Imunon, Inc. is listed on NASDAQ under the ticker symbol IMNN, with the company's address given as 997 Lenox Drive, Suite 100, Lawrenceville, New Jersey 08648.

What Was Disclosed

The filing disclosed two acquisitions of Imunon common stock by CMO Douglas Faller on October 23, 2026: a stock grant of 26,741 shares and 1,092 shares issued in lieu of cash salary, both at $1.235 per share, with no securities disposed of.